Brain Scientific, Creator of Next Gen Neurology Technologies, Announces Regulation A+ Offering
Widening Its Investor Network Will Allow Brain Scientific to Continue Its Work in Creating Advanced Technology Devices and Software for the Neurology Market NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced it has launched a Regulation A+ equity crowdfunding campaign following the qualification of its Form 1-A offering circular by the…